Australia gearing up for more price cuts this year and next
This article was originally published in Scrip
Executive Summary
Innovator companies are facing the prospect of more significant falls in the prices of medicines paid for by the Pharmaceutical Benefits Scheme (PBS) after the Australian government launched a consultation on changes to the price disclosure process that are due to take effect in October next year.